OBIO – Capital Access Advisory Program (CAAP)

Receive up to $250,000 in Potential Funding.

The Ontario Bioscience Innovation Organization (OBIO) is an Ontario not-for-profit membership-based organization that strives to help further the commercialization of Ontario’s human health science. The Capital Access Advisory Program (CAAP) operates downstream from existing entrepreneurship programs and focuses on accelerating technology commercialization, working towards Series A financing and strategic partnerships.

Attention: This program is currently closed. You can speak with a member of our team about future intake periods or similar funding programs you may be eligible for, get email updates through our weekly newsletter, or look through our list of available funding programs in our directory page.

Get Funding Help

Quick View

Funding Amount

Capital Access Advisory Program: Amount of funding your company receives depends on pitch success.

Eligible Applicants

Capital Access Advisory Program: A private, promising health science company in Ontario developing human health products in therapeutics, medical devices, diagnostics, or digital health tech.

Eligible Activities

Capital Access Advisory Program: Receive guidance from a network of international investors, executives, and business experts on strategy for a successful raise.

Deadline to Apply

Speak with a member of our team about current intakes for this program and other funding programs your business may be eligible for.

800+

Annual Funding Applications Supported

Apply for This Funding Program

Give your application the best chance of approval. Ryan supports the writing of applications for more than 100 Canadian federal and provincial government grants, tax credits, and no-interest loan programs.

Amount of Funding

Your company’s pitch to investors at the OBIO Investment Summit will determine the amount of funding your company receives from the Capital Access Advisory Program.

Eligible Applicants

A private, promising health science company in Ontario;
Developing human health products in therapeutics, medical devices, diagnostics, or digital health tech;
Has closed or is about to close a “seed” investment within six months;
Intent on raising series A financing in 2022 to 2023;
Has enough resources and funding runway to reach next key value inflection points to allow for their Series A raise; and
Is a company that would benefit substantially from coaching/participating in CAAP to advance their business strategy and raise capital.

Accessible Technology Program (ATP)

Eligible Activities

Receive guidance from international Steering Committee of investors, healthcare executives, and business experts on strategy for a successful raise;
Access to a network of advisors with expertise in technology commercialization, business development, fundraising and negotiations; and
Investor readiness, targeting and introductions.

Eligible Activities

Program Deadline

Speak with a member of our team to find the latest intake period info for this program or subscribe to our newsletter to be notified.

Average of
Time Saving

95%

Throughout the application process

Apply for Funding

Successfully applying for the right funding program at the right time, focusing on the right topics is no easy challenge. We provide an average 95% time savings to our clients, compared to businesses that apply for funding in-house.

OBIO – Capital Access Advisory Program (CAAP)

Receive up to $250,000 in Potential Funding.